| XEN445 |
(S)-2-(3-(PYRIDIN-2-YLMETHOXY)PYRROLIDIN-1-YL)-5-(TRIFLUOROMETHYL)BENZOIC ACID. HCL |
1515856-92-4 |
| D-Phenylalanine, N-benzoyl-L-tryptophyl-, methyl ester |
D-Phenylalanine, N-benzoyl-L-tryptophyl-, methyl ester |
1435265-06-7 |
| ODM203 |
ODM203 |
1430723-35-5 |
| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 |
1429881-91-3 |
| ML 18 |
(S)-3-(1H-吲哚-3-基)-N-((1-(4-甲氧基苯基)环己基)甲基)-2-(3-(4-硝基苯基)脲基)丙酰胺 |
1422269-30-4 |
| JNK-IN-8 |
JNK-IN-8 |
1410880-22-6 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| 2-(4-((2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl)phenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole |
2-(4-((2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl)phenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole |
1401728-56-0 |
| BS-181 HCl |
BS181 |
1397219-81-6 |
| 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
EPZ005687 |
1396772-26-1 |
| BIX 01294 |
BIX 01294三盐酸盐水合物 |
1392399-03-9 |
| LY3023414 |
LY-3023414 |
1386874-06-1 |
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
| pf-5274857 |
PF-5274857 |
1373615-35-0 |
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
| N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide |
AGI-5198 (IDH-C35) |
1355326-35-0 |
| EW-7197 |
EW-7197 |
1352608-82-2 |
| MK5172 |
格佐匹韦 |
1350514-68-9 |
| CID-49830258 |
ML240 |
1346527-98-7 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
GSK126 |
1346574-57-9 |
